Paragon's rapid discovery engine is augmented through partnerships with newly formed or existing companies positioned to rapidly advance these biologics through clinical development.
To support our discovery and optimization efforts, we employ a broad range of protein engineering technologies. Our experienced team of drug discovery leaders works with a robust ecosystem of partners to discover and advance transformative programs.
Paragon Labs was launched by as a specialized hub dedicated to the rapid and efficient discovery of best-in-class complex biologics to address high unmet need.
Leveraging a dedicated in-house team of scientific experts in biologics development, Paragon pursues unique therapeutic concepts and enables rapid proof-of-concept validation by following our proven approach to drug discovery.
To date, Paragon technology and assets have served as the foundation of eight legacy partner companies (six of which are highlighted below).
Fairmount is dedicated to investing in promising new therapies to be developed by biotechnology and life science companies.
Paragon Labs is led by a collaborative team of innovators with deep expertise in biologics engineering, drug discovery and development, intellectual property, strategy, and finance. Together, we are motivated to catalyze breakthrough science with the goal of improving the quality of life for patients.
We are excited about the future as we advance our state-of-the-art science, and while we may not be hiring for a specific role at the moment, we are always interested in connecting with great talent. Submit your resume to be considered for future openings that align with your background and interests.
We can’t wait to meet you.
Our values reflect who we are and guide our actions and decisions, empowering everyone to contribute meaningfully to our shared purpose.
We respect and value each other’s ideas and contributions. We achieve more by working together.
